Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H Scheller

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The EMBO Journal|February 7, 2013
Rac and Rab GTPases dual effector Nischarin regulates vesicle maturation to facilitate survival of intracellular bacteriaCoenraad Kuijl, Manohar Pilli, Suresh K Alahari, et al.
Plant Physiology|May 15, 2003
Sharing publication-related data and materials: responsibilities of authorship in the life sciencesThomas R Cech, Sean R Eddy, David Eisenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
Death-receptor activation halts clathrin-dependent endocytosisCary D Austin, David A Lawrence, Andrew A Peden, et al.
Cell|June 19, 2007
A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesisMaxence V Nachury, Alexander V Loktev, Qihong Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2011
Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosomeChristopher J Westlake, Lisa M Baye, Maxence V Nachury, et al.
Mabs|October 15, 2013
An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteinsMeredith Hazen, Sunil Bhakta, Rajesh Vij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancerJagath R Junutula, Kelly M Flagella, Richard A Graham, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Journal of Medicinal Chemistry|September 6, 2014
Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineeringThomas H Pillow, Janet Tien, Kathryn L Parsons-Reponte, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The EMBO Journal|February 7, 2013
Rac and Rab GTPases dual effector Nischarin regulates vesicle maturation to facilitate survival of intracellular bacteriaCoenraad Kuijl, Manohar Pilli, Suresh K Alahari, et al.
Plant Physiology|May 15, 2003
Sharing publication-related data and materials: responsibilities of authorship in the life sciencesThomas R Cech, Sean R Eddy, David Eisenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
Death-receptor activation halts clathrin-dependent endocytosisCary D Austin, David A Lawrence, Andrew A Peden, et al.
Cell|June 19, 2007
A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesisMaxence V Nachury, Alexander V Loktev, Qihong Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2011
Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosomeChristopher J Westlake, Lisa M Baye, Maxence V Nachury, et al.
Mabs|October 15, 2013
An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteinsMeredith Hazen, Sunil Bhakta, Rajesh Vij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancerJagath R Junutula, Kelly M Flagella, Richard A Graham, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Journal of Medicinal Chemistry|September 6, 2014
Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineeringThomas H Pillow, Janet Tien, Kathryn L Parsons-Reponte, et al.
Pageof 4